FDA Inspection 1248911 — American Red Cross Blood Services - Southwest Region

American Red Cross Blood Services - Southwest Region — FEI 3008937564

The FDA completed an inspection of American Red Cross Blood Services - Southwest Region on August 27, 2024 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 27, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Houston, TX (United States)